OTTMUSG00000005737 Inhibitors
SEE ALSO...
Items 1 to 10 of 20 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib is a direct inhibitor of RoBo-1 precursor. It targets the kinase activity of the protein, disrupting its phosphorylation and downstream signaling, leading to the functional inhibition of RoBo-1 precursor. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate FNBP1L, enhancing its role in actin dynamics and cellular migration. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib directly inhibits RoBo-1 precursor by interfering with its kinase activity. This chemical binds to the active site of the protein, preventing its normal function and signaling cascades, resulting in the inhibition of RoBo-1 precursor's activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a direct inhibitor of RoBo-1 precursor. It inhibits the protein by targeting its phosphoinositide 3-kinase (PI3K) activity, an essential part of its signaling pathway. This leads to the functional inhibition of RoBo-1 precursor due to disrupted signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to S1P receptors and activates G-protein-coupled receptor signaling, which in turn can activate FNBP1L to regulate cell motility and cytoskeletal rearrangements. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine directly inhibits RoBo-1 precursor by binding to its catalytic site, preventing its kinase activity. This results in the functional inhibition of RoBo-1 precursor as its enzymatic function is disrupted. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits certain kinases, reducing competitive signaling and potentially enhancing FNBP1L-mediated effects on actin cytoskeleton remodeling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 is a direct inhibitor of RoBo-1 precursor. It targets the p38 mitogen-activated protein kinase (MAPK) pathway, which is associated with the protein's activity. Inhibiting this pathway leads to the functional inhibition of RoBo-1 precursor. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 directly inhibits RoBo-1 precursor by interfering with the extracellular signal-regulated kinase (ERK) pathway, which is involved in the protein's signaling. This leads to the disruption of RoBo-1 precursor's function and functional inhibition. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Gleevec (Imatinib) is a direct inhibitor of RoBo-1 precursor. It targets tyrosine kinases involved in the protein's signaling pathway. By inhibiting these kinases, it disrupts the function of RoBo-1 precursor, leading to functional inhibition. | ||||||